Advertisement
Screener

BIORESTORATIVE THERAPIES, INC. (BRTX) Graph

BRTX Revenue Flow

Filed revenue amounts for 2026-01-01 to 2026-03-31. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2022-09-30: Net income -$4.66M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

BRTX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product$11.87KRoyalty$11.30KRevenue$23.17KCost of revenue$7.38KGross profit$15.78KOperating expenses$3.40MOperating income-$3.39MOther income, net$5.73KResearch & development$1.93M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 1 month

Period endNet income
2022-09-30-$4.66M

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesNet income
2026-03-31$23.17K$7.38K$1.93M$3.40M-$2.15M
2025-12-31$19.60K*$1.64K*$2.63M*$3.84M*-$3.21M*
2025-09-30$11.80K$10.57K$2.59M$3.71M-$3.04M
2025-06-30$303.30K$8.73K$2.23M$3.60M-$2.66M
2025-03-31$25.00K$2.91K$2.65M$4.83M-$5.34M
2024-09-30$233.60K$18.24K$1.45M$2.50M-$1.09M
2024-06-30$89.10K$6.49K$1.45M$2.55M-$4.03M
2024-03-31$35.00K(m)$1.06M$4.14M-$2.22M
2023-09-30$30.70K(m)$809.82K$3.14M$4.77M
2023-06-30$64.50K(m)$902.89K$3.18M-$5.71M
2023-03-31$31.30K(m)$1.23M$5.81M-$7.17M
2022-09-30$29.00K(m)$989.17K$4.64M-$5.45M
2022-06-30$71.10K(m)$1.08M$4.70M$3.10M
2022-03-31$16.00K(m)$775.34K$5.07M-$8.21M
2021-09-30$8.00K(m)$237.41K$3.70M-$4.18M
2021-06-30$15.00K(m)$160.90K$3.57M-$4.06M
2021-03-31$18.00K(m)$165.25K$15.07M-$15.65M
2020-09-30$15.00K(m)$251.04K$625.26K-$836.26K
2020-06-30$19.00K(m)$261.55K$480.59K$2.88M
2020-03-31$26.00K(m)$186.33K$844.99K-$7.55M
2019-09-30$38.00K(m)$409.81K$1.86M-$5.06M
2019-06-30$31.00K(m)$441.72K$2.16M-$4.16M
2019-03-31$29.00K(m)$455.01K$2.36M-$3.88M
2018-09-30$26.00K(m)$357.44K$1.21M-$2.93M
2018-06-30$37.00K(m)$372.81K$2.09M-$3.51M
2018-03-31$19.00K(m)$407.13K$2.25M-$2.51M
2017-09-30$16.00K(m)$490.65K$1.76M-$2.05M
2017-06-30$20.00K(m)$610.73K$2.59M-$2.75M
2017-03-31$7.00K(m)$805.85K$2.50M-$2.79M
2016-09-30$5.00K(m)$656.17K$1.72M-$1.83M
2016-06-30$16.16K(m)$608.69K$2.16M-$2.26M
2016-03-31$9.13K(m)$866.04K$2.08M-$2.49M
2015-09-30$96.12K(m)$615.65K$1.54M-$1.62M
2015-06-30$148.76K(m)$452.49K$1.34M-$1.42M
2015-03-31$184.90K(m)$406.86K$1.73M-$1.76M
2014-09-30$159.93K(m)$290.71K$989.82K-$1.10M
2014-06-30$175.94K(m)$293.33K$1.42M-$1.33M
2014-03-31$375.00(m)$493.74K$1.43M-$1.67M
2013-09-30$125.00(m)$414.92K$1.13M-$1.30M
2013-06-30$425.00(m)$372.92K$1.11M-$1.25M
2013-03-31$1.13K(m)$400.44K$1.30M-$1.57M
2012-09-30$5.22K(m)$275.31K$1.21M-$1.48M
2012-06-30$10.00K(m)$119.35K$1.35M-$1.65M
2012-03-31$0.00(m)$53.70K$1.32M-$1.49M
2011-09-30$0.00(m)$0.00$853.00K-$1.01M
2011-06-30(m)(m)(m)$1.04M-$1.20M
2011-03-31(m)(m)(m)$1.02M-$1.11M
2010-09-30(m)(m)(m)$370.19K-$388.77K
2010-06-30(m)(m)(m)$178.73K-$197.29K

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesNet income
2025-06-30$328.30K$11.64K$4.87M$8.43M-$8.00M
2024-06-30$124.10K$6.49K$3.53M$6.70M-$6.25M
2023-06-30$95.80K(m)$2.13M$8.99M-$12.88M
2022-06-30$87.10K(m)$1.85M$9.77M-$5.11M
2021-06-30$33.00K(m)$326.15K$18.64M-$19.72M
2020-06-30$45.00K(m)$447.88K$1.33M-$4.68M
2019-06-30$60.00K(m)$896.73K$4.52M-$8.04M
2018-06-30$56.00K(m)$779.95K$4.34M-$6.02M
2017-06-30$27.00K(m)$1.42M$5.09M-$5.53M
2016-06-30$25.28K(m)$1.47M$4.24M-$4.75M
2015-06-30$333.67K(m)$859.34K$3.07M-$3.18M
2014-06-30$176.32K(m)$787.07K$2.84M-$3.00M
2013-06-30$1.55K(m)$773.36K$2.41M-$2.82M
2012-06-30$10.00K(m)$173.05K$2.67M-$3.14M
2011-06-30(m)(m)(m)$2.06M-$2.32M
2010-06-30(m)(m)$11.62K$522.73K-$662.66K

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesNet income
2025-09-30$340.10K$22.21K$7.47M$12.14M-$11.03M
2024-09-30$357.70K$24.73K$5.00M$9.20M-$7.34M
2023-09-30$126.50K(m)$2.94M$12.13M-$8.11M
2022-09-30$116.10K(m)$2.84M$14.41M-$10.55M
2021-09-30$41.00K(m)$563.56K$22.34M-$23.90M
2020-09-30$60.00K(m)$698.92K$1.96M-$5.51M
2019-09-30$98.00K(m)$1.31M$6.37M-$13.10M
2018-09-30$82.00K(m)$1.14M$5.55M-$8.95M
2017-09-30$43.00K(m)$1.91M$6.85M-$7.59M
2016-09-30$30.28K(m)$2.13M$5.96M-$6.58M
2015-09-30$429.79K(m)$1.47M$4.61M-$4.80M
2014-09-30$336.25K(m)$1.08M$3.83M-$4.10M
2013-09-30$1.68K(m)$1.19M$3.54M-$4.12M
2012-09-30$15.22K(m)$448.36K$3.88M-$4.62M
2011-09-30$0.00(m)$0.00$2.91M-$3.33M
2010-09-30(m)(m)$11.62K$892.93K-$1.05M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$359.70K$23.84K$10.09M$15.98M(m)-$14.24M
2024-12-31$401.00K$28.07K$6.71M$11.93M(m)-$8.98M
2023-12-31$145.80K(m)$4.03M$15.37M(m)-$10.42M
2022-12-31$119.80K(m)$3.51M$19.09M(m)-$13.22M
2021-12-31$46.00K(m)$729.06K$26.35M(m)-$44.30M
2020-12-31$77.00K(m)$876.83K$2.83M(m)-$11.27M
2019-12-31$130.00K(m)$1.72M$8.56M(m)-$14.65M
2018-12-31$111.00K(m)$1.51M$7.76M(m)-$12.52M
2017-12-31$81.00K(m)$2.15M$8.46M(m)-$9.44M
2016-12-31$36.35K(m)$2.88M$7.82M(m)-$8.64M
2015-12-31$628.91K(m)$2.11M$7.54M$0.00-$7.92M
2014-12-31$416.00K(m)$1.43M$5.12M$0.00-$5.59M
2013-12-31$1.68K(m)$1.59M$4.75M$0.00-$5.75M
2012-12-31$15.59K(m)$756.78K$5.59M(m)-$6.54M
2011-12-31$0.00(m)$12.00K$3.55M(m)-$4.07M
2010-12-31(m)(m)$11.62K$2.07M(m)-$2.26M
2009-12-31(m)(m)(m)(m)(m)-$1.20M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Park Dental Partners, Inc. (PARK)United States$0.094B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
agilon health, inc. (AGL)United States$1.272B-7.76
Progyny, Inc. (PGNY)United States$1.994B28.37
Sotera Health Co (SHC)United States$5.271B30.96
DAVITA INC. (DVA)United States$11.147B16.80